Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong · Delayed Price · Currency is HKD 6.37
-0.02 (-0.31%)
Apr 21, 2026, 4:08 PM HKT
HKG:0719 Revenue
In the year 2025, Shandong Xinhua Pharmaceutical Company had annual revenue of 8.75B CNY with 3.41% growth. Shandong Xinhua Pharmaceutical Company had revenue of 1.99B in the quarter ending December 31, 2025, with 15.01% growth.
Revenue
8.75B CNY
Revenue Growth
+3.41%
P/S Ratio
0.99
Revenue / Employee
1.22M CNY
Employees
7,159
Market Cap
9.63B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.75B | 288.41M | 3.41% |
| Dec 31, 2024 | 8.47B | 365.47M | 4.51% |
| Dec 31, 2023 | 8.10B | 597.86M | 7.97% |
| Jan 1, 2023 | 7.50B | 942.91M | 14.37% |
| Dec 31, 2021 | 6.56B | 554.49M | 9.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Revenue RankingsShandong Xinhua Pharmaceutical Company News
- 2 months ago - Viral dance challenge lifted Chinese ibuprofen maker’s shares – now they are languishing - South China Morning Post